Cerebrospinal Fluid Protein Biomarkers for Alzheimer’s Disease
Summary: The introduction of acetylcholine esterase (AChE) inhibitors as a symptomatic treatment of Alzheimer’s disease (AD) has made patients seek medical advice at an earlier stage of the disease. This has highlighted the importance of diagnostic markers for early AD. However, there is no clinical...
Na minha lista:
| Publicado no: | NeuroRx |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Am. Soc. for Experimental NeuroTherapeutics
2004
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC534929/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15717022/ https://ncbi.nlm.nih.govhttps://doi.org/10.1602/neurorx.1.2.213 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|